Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Basic Research in Cardiology
Metadata
Title
Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo
Publication date
01-11-2012
Published in
Basic Research in Cardiology / Issue 6/2012
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI
https://doi.org/10.1007/s00395-012-0308-y

Other articles of this Issue 6/2012

Basic Research in Cardiology 6/2012 Go to the issue

Original Contribution

Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products

Original Contribution

Impaired left ventricular function in the presence of preserved ejection in chronic hypertensive conscious pigs

Report

Trials, tribulations and speculation! Report from the 7th Biennial Hatter Cardiovascular Institute Workshop

Original Contribution

Dronedarone reduces arterial thrombus formation

Original Contribution

Increased afterload induces pathological cardiac hypertrophy: a new in vitro model

Original Contribution

Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits